Harald Zilg

Title: The Innovations of Harald Zilg

Introduction

Harald Zilg is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 2 patents, Zilg's work focuses on the development of compounds that have potential therapeutic applications.

Latest Patents

One of Zilg's latest patents is titled "Anthracyclinone glycosides containing an n-oxidized sugar." This invention relates to anthracycline derivatives that include an N-oxidized sugar or a combination of N-oxidized sugars. The patent outlines a chemical process for preparing these compounds, which are intended for use as medicaments in the treatment of malignant tumors. Another significant patent is the "Process for the stabilization of hematin," which describes a method for stabilizing hematin using albumin. The resulting product is a medicament with enhanced properties.

Career Highlights

Throughout his career, Zilg has worked with prominent companies in the pharmaceutical industry, including Behringwerke Aktiengesellschaft and Hoechst Aktiengesellschaft. His experience in these organizations has contributed to his expertise in developing innovative medicinal compounds.

Collaborations

Zilg has collaborated with notable colleagues such as Hans G Berscheid and Hans-Wolfram Fehlhaber. These partnerships have likely enriched his research and development efforts, leading to advancements in his field.

Conclusion

Harald Zilg's contributions to medicinal chemistry through his patents demonstrate his commitment to innovation and improving therapeutic options. His work continues to impact the field positively, showcasing the importance of research and collaboration in advancing medical science.